{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:58:39Z","timestamp":1792699119197,"version":"4.5.0"},"reference-count":191,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Acne vulgaris is a common dermatologic disorder that affects approximately 85% of teenagers, which significantly impacts the quality of life in adolescents. It is a chronic disease of the sebaceous follicles that is multifactorial in etiology. Topical treatment is the first choice for mild and moderate acne, while systemic therapy is reserved for severe and certain moderate cases. Topical treatments include retinoids (e.g., tretinoin and adapalene), antibiotics (e.g., clindamycine), and other agents (e.g., benzoyl peroxide and azelaic acid), often applied in combination. The mechanisms of action include antimicrobial, anti-inflammatory, and keratolytic activities, as well as sebum secretion reduction, and the normalization of follicular keratinization. However, these topical agents commonly induce side effects, such as dryness, burning, stinging, peeling, redness, erythema, and photosensitivity. Therefore, there is a need to reduce the side effects of anti-acne drugs, while maintaining or enhancing their therapeutic effectiveness. This article aims to comprehensively outline nanotechnology strategies, particularly the use of phospholipid-based nanocarriers like liposomes and related vesicles, to enhance therapeutic efficacy, skin tolerability, and patient compliance in the treatment of acne vulgaris. In addition, novel active ingredients encapsulated in vesicles beyond those recommended in official guidelines are discussed.<\/jats:p>","DOI":"10.3390\/pharmaceutics16030309","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T11:28:47Z","timestamp":1708601327000},"page":"309","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Liposomes and Other Nanocarriers for the Treatment of Acne Vulgaris: Improved Therapeutic Efficacy and Skin Tolerability"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2111-8943","authenticated-orcid":false,"given":"Nina","family":"Dragicevic","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Singidunum University, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard I.","family":"Maibach","sequence":"additional","affiliation":[{"name":"Dermatology Department, University of California, San Francisco, CA 94143-0989, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"ref_1","first-page":"892","article-title":"Acne in Adolescent","volume":"46","author":"Gebauer","year":"2017","journal-title":"Aust. Fam. Physician"},{"key":"ref_2","unstructured":"(2023, February 19). Acne Vulgaris: Establishing Effectiveness of Drugs Intended for Treatment|FDA, Available online: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/acne-vulgaris-establishing-effectiveness-drugs-intended-treatment."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Reynolds, R.V., Yeung, H., Cheng, C.E., Cook-Bolden, F., Desai, S.R., Druby, K.M., Freeman, E.E., Keri, J.E., Stein Gold, L.F., and Tan, J.K.L. (2023). FROM THE ACADEMY Guidelines of Care for the Management of Acne Vulgaris. J. Am. Dermatol., in press.","DOI":"10.1016\/j.jaad.2023.12.017"},{"key":"ref_4","first-page":"e1","article-title":"Methods Report on the Development of the European Evidence-Based (S3) Guideline for the Treatment of Acne\u2013Update 2016","volume":"30","author":"Nast","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_5","unstructured":"National Institute for Health and Care Exellence, British Association of Dermatologists (2024, January 13). Acne Vulgaris: Management, NICE Guideline, Updated 7th December 2023. Available online: https:\/\/www.nice.org.uk\/guidance\/ng198\/resources\/acne-vulgaris-management-pdf-66142088866501."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14656566.2020.1813279","article-title":"An Overview of Sarecycline for the Treatment of Moderate-to-Severe Acne Vulgaris","volume":"22","year":"2021","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/276260","article-title":"Carrier-Based Drug Delivery System for Treatment of Acne","volume":"2014","author":"Vyas","year":"2014","journal-title":"Sci. World J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3399\/bjgp21X717977","article-title":"New NICE Guidance on Acne Vulgaris: Implications for First-Line Management in Primary Care","volume":"71","author":"Wilcock","year":"2021","journal-title":"Br. J. Gen. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Latter, G., Grice, J.E., Mohammed, Y., Roberts, M.S., and Benson, H.A.E. (2019). Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11100490"},{"key":"ref_10","unstructured":"(2024, February 13). AKLIEF\u00ae (Trifarotene) Cream, 0.005%. Available online: https:\/\/www.aklief.com\/."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40257-021-00594-8","article-title":"50 Years of Topical Retinoids for Acne: Evolution of Treatment","volume":"22","author":"Baldwin","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_12","unstructured":"(2024, February 08). Best Acne Treatment: The Pros and Cons of the Most Used Topical Acne Medications. Available online: https:\/\/miiskin.com\/acne\/medications\/best-acne-treatment\/."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.clindermatol.2016.10.008","article-title":"Propionibacterium Acnes and Antimicrobial Resistance in Acne","volume":"35","author":"Dessinioti","year":"2017","journal-title":"Clin. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bhalani, D.V., Nutan, B., Kumar, A., and Singh Chandel, A.K. (2022). Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics. Biomedicines, 10.","DOI":"10.3390\/biomedicines10092055"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijpharm.2013.08.019","article-title":"Nano-Lipoidal Carriers of Tretinoin with Enhanced Percutaneous Absorption, Photostability, Biocompatibility and Anti-Psoriatic Activity","volume":"456","author":"Raza","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2016.12.022","article-title":"Topical and Cutaneous Delivery Using Nanosystems","volume":"247","author":"Roberts","year":"2017","journal-title":"J. Control. Release"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Dragicevic, N., and Maibach, H. (2016). Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Nanocarriers, Springer.","DOI":"10.1007\/978-3-662-47862-2"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Dragicevic, N., Verma, D.D., and Fahr, A. (2016). Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Nanocarriers, Springer.","DOI":"10.1007\/978-3-662-47862-2"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Dragicevic, N. (2021). Invasomes as Drug Nanocarriers for Innovative Pharmaceutical Dosage Forms, CRC Press. [1st ed.].","DOI":"10.1201\/9781003187332"},{"key":"ref_20","unstructured":"Muzzalupo, R. (2016). Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Nanocarriers, Springer."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/17425247.2020.1727883","article-title":"SLN and NLC for Topical, Dermal, and Transdermal Drug Delivery","volume":"17","author":"Souto","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_22","first-page":"36","article-title":"Enhancing Topical Pharmacotherapy for Acne and Rosacea: Vehicle Choices and Outcomes","volume":"15","author":"Green","year":"2022","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.2174\/0929867325666180313110917","article-title":"Nanotechnological Advances for Cutaneous Release of Tretinoin: An Approach to Minimize Side Effects and Improve Therapeutic Efficacy","volume":"25","author":"Raminelli","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpharm.2018.10.024","article-title":"Azithromycin-Loaded Liposomes for Enhanced Topical Treatment of Methicillin-Resistant Staphyloccocus Aureus (MRSA) Infections","volume":"553","author":"Rukavina","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"119398","DOI":"10.1016\/j.ijpharm.2020.119398","article-title":"What\u2019s New in the Field of Phospholipid Vesicular Nanocarriers for Skin Drug Delivery","volume":"583","author":"Lai","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejps.2017.10.032","article-title":"Experimental Optimization of Lornoxicam Liposomes for Sustained Topical Delivery","volume":"112","author":"Joseph","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1208\/s12249-018-1166-1","article-title":"Optimization and Characterization of Thymoquinone-Loaded Liposomes with Enhanced Topical Anti-Inflammatory Activity","volume":"19","author":"Mostafa","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/ics.12394","article-title":"Skin Delivery of Hydrophilic Molecules from Liposomes and Polysaccharide-Coated Liposomes","volume":"39","author":"Belhaj","year":"2017","journal-title":"Int. J. Cosmet. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijpharm.2016.04.008","article-title":"Combination of Argan Oil and Phospholipids for the Development of an Effective Liposome-like Formulation Able to Improve Skin Hydration and Allantoin Dermal Delivery","volume":"505","author":"Manca","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.biomaterials.2017.07.009","article-title":"Combined Photodynamic and Antibiotic Therapy for Skin Disorder via Lipase-Sensitive Liposomes with Enhanced Antimicrobial Performance","volume":"141","author":"Jeong","year":"2017","journal-title":"Biomaterials"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2016.07.003","article-title":"Advances in Psoriasis Physiopathology and Treatments: Up to Date of Mechanistic Insights and Perspectives of Novel Therapies Based on Innovative Skin Drug Delivery Systems (ISDDS)","volume":"239","author":"Sala","year":"2016","journal-title":"J. Control. Release"},{"key":"ref_32","first-page":"1497","article-title":"Topical Delivery of Doxepin Using Liposome Containing Cream: An Emerging Approach in Enhancing Skin Retention","volume":"36","author":"Asl","year":"2023","journal-title":"Pak. J. Pharm. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ho, M.J., Park, D.W., and Kang, M.J. (2023). Design of Novel Tricaprylin-Incorporated Multi-Layered Liposomal System for Skin Delivery of Ascorbic Acid with Improved Chemical Stability. Pharmaceuticals, 16.","DOI":"10.3390\/ph16010121"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2174\/1389450115666140113100338","article-title":"A Review on Skin Targeted Delivery of Bioactives as Ultradeformable Vesicles: Overcoming the Penetration Problem","volume":"15","author":"Priyanka","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.2174\/13816128113199990369","article-title":"Needle-Free Gene Delivery Through the Skin: An Overview of Recent Strategies","volume":"19","author":"Elsabahy","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/10717544.2016.1228718","article-title":"Skin Delivery of Epigallocatechin-3-Gallate (EGCG) and Hyaluronic Acid Loaded Nano-Transfersomes for Antioxidant and Anti-Aging Effects in UV Radiation Induced Skin Damage","volume":"24","author":"Avadhani","year":"2017","journal-title":"Drug Deliv."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.2147\/IJN.S86186","article-title":"Development, Characterization, and Skin Delivery Studies of Related Ultradeformable Vesicles: Transfersomes, Ethosomes, and Transethosomes","volume":"10","author":"Ascenso","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2018.09.009","article-title":"Tocopherol-Loaded Transfersomes: In Vitro Antioxidant Activity and Efficacy in Skin Regeneration","volume":"551","author":"Caddeo","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2019.04.001","article-title":"Comparative Study of Liposomes, Ethosomes and Transfersomes as Carriers for Enhancing the Transdermal Delivery of Diflunisal: In Vitro and in Vivo Evaluation","volume":"563","author":"Kassem","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1002\/jps.24096","article-title":"Evaluation of Skin Viability Effect on Ethosome and Liposome-Mediated Psoralen Delivery via Cell Uptake","volume":"103","author":"Zhang","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"105411","DOI":"10.1016\/j.ejps.2020.105411","article-title":"Vesicular Elastic Liposomes for Transdermal Delivery of Rifampicin: In-Vitro, in-Vivo and in Silico GastroPlusTM Prediction Studies","volume":"151","author":"Hussain","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_42","unstructured":"Cevc, G., and Chopra, A. (2016). Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Nanocarriers, Springer."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0142-9612(00)00063-6","article-title":"Carriers for Skin Delivery of Trihexyphenidyl HCl: Ethosomes vs Liposomes Carriers for Skin Delivery of Trihexyphenidyl HCl: Ethosomes vs. Liposomes","volume":"21","author":"Touitou","year":"2000","journal-title":"Biomaterials"},{"key":"ref_44","unstructured":"Manconi, M., Sinico, C., and Fadda, A.M. (2016). Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement: Nanocarriers, Springer."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2174\/1389450115666140804224024","article-title":"Penetration Enhancer-Containing Vesicles: Does the Penetration Enhancer Structure Affect Topical Drug Delivery?","volume":"16","author":"Caddeo","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"121878","DOI":"10.1016\/j.ijpharm.2022.121878","article-title":"A State-of-the-Art Review on the Recent Advances of Niosomes as a Targeted Drug Delivery System","volume":"624","author":"Yasamineh","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ajps.2022.04.003","article-title":"Hair Follicle-Targeting Drug Delivery Strategies for the Management of Hair Follicle-Associated Disorders","volume":"17","author":"Gu","year":"2022","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1530004","DOI":"10.1142\/S1793545815300049","article-title":"Hair Follicles as a Target Structure for Nanoparticles","volume":"8","author":"Lademann","year":"2015","journal-title":"J. Innov. Opt. Health Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1211\/jpp.58.4.0001","article-title":"Can Drug-Bearing Liposomes Penetrate Intact Skin?","volume":"58","author":"Williams","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1517\/17425247.5.6.665","article-title":"Novel Vesicular and Particulate Drug Delivery Systems for Topical Treatment of Acne","volume":"5","author":"Castro","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"20023","DOI":"10.1038\/s41598-023-47302-6","article-title":"Optimization, Characterization, and Follicular Targeting Assessment of Tretinoin and Bicalutamide Loaded Niosomes","volume":"13","author":"Ghasemiyeh","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.2147\/IJN.S147226","article-title":"Anti-MRSA Malleable Liposomes Carrying Chloramphenicol for Ameliorating Hair Follicle Targeting","volume":"12","author":"Hsu","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e12778","DOI":"10.1111\/dth.12778","article-title":"A Liposome-Based Formulation Containing Equol, Dihomo-\u03b3-Linolenic Acid and Propionyl-l-Carnitine to Prevent and Treat Hair Loss: A Prospective Investigation","volume":"32","author":"Brotzu","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/03639045.2015.1082580","article-title":"Intradermal and Follicular Delivery of Adapalene Liposomes","volume":"42","author":"Kumar","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.addr.2018.02.003","article-title":"Combined Use of Nanocarriers and Physical Methods for Percutaneous Penetration Enhancement","volume":"127","author":"Dragicevic","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_56","unstructured":"M\u00fcller, R.H., Zhai, X., Romero, G.B., and Keck, C.M. (2016). Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement, Springer."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"105383","DOI":"10.1016\/j.jddst.2024.105383","article-title":"Coenzyme Q10-Loaded Nanoemulsion Hydrophilic Gel: Development, Characterization, Stability Evaluation and in Vivo Effects in Skin","volume":"92","author":"Dragicevic","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_58","unstructured":"Lapteva, M., M\u00f6ller, M., and Kalia, Y.N. (2016). Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement, Springer."},{"key":"ref_59","unstructured":"Abdel-Mottaleb, M.M.A., and Lamprecht, A. (2016). Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement, Springer."},{"key":"ref_60","unstructured":"Patzelt, A., and Lademann, J. (2015). Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement, Springer."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"123349","DOI":"10.1016\/j.ijpharm.2023.123349","article-title":"Polymeric Micelles for Cutaneous Delivery of the Hedgehog Pathway Inhibitor TAK-441: Formulation Development and Cutaneous Biodistribution in Porcine and Human Skin","volume":"644","author":"Darade","year":"2023","journal-title":"Int. J. Pharm."},{"key":"ref_62","unstructured":"Klang, V., Schwarz, J.C., and Valenta, C. (2015). Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement, Springer."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Casula, L., Pireddu, R., Cardia, M.C., Pini, E., Valenti, D., Schlich, M., Sinico, C., Marceddu, S., Dragi\u0107evi\u0107, N., and Fadda, A.M. (2023). Nanosuspension-Based Dissolvable Microneedle Arrays to Enhance Diclofenac Skin Delivery. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15092308"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"102662","DOI":"10.1016\/j.jddst.2021.102662","article-title":"Nanocrystals for Improved Topical Delivery of Medium Soluble Drug: A Case Study of Acyclovir","volume":"65","author":"Wadhawan","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Zhao, T., Zhou, M., Wu, R., Wang, H., Zouboulis, C.C., Zhu, M., and Lee, M. (2023). Dendrimer-Conjugated Isotretinoin for Controlled Transdermal Drug Delivery. J. Nanobiotechnol., 21.","DOI":"10.1186\/s12951-023-02052-5"},{"key":"ref_66","unstructured":"European Medicines Agency (2024, January 13). Annex I. List of the Names, Pharmaceutical Forms, Strengths of the Medicinal Products, Route of Administration, Marketing Authorisation Holders, Packaging and Package Sizes in the Member States (for Retinoids Containing Medicinal Products). Available online: https:\/\/ec.europa.eu\/health\/documents\/community-register\/2003\/200310176820\/anx_6820_en.pdf."},{"key":"ref_67","unstructured":"(2024, January 13). Retinoid-Containing Medicinal Products\u2014Referral. Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/retinoid-containing-medicinal-products."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/jdv.13776","article-title":"European Evidence-Based (S3) Guideline for the Treatment of Acne\u2013Update 2016\u2013Short Version","volume":"30","author":"Nast","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40257-019-00423-z","article-title":"Topical Retinoids in Acne Vulgaris: A Systematic Review","volume":"20","author":"Kolli","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpharm.2005.01.012","article-title":"Accelerated Photostability Study of Tretinoin and Isotretinoin in Liposome Formulations","volume":"293","author":"Ioele","year":"2005","journal-title":"Int. J. Pharm."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jconrel.2004.11.020","article-title":"Liposomes as Carriers for Dermal Delivery of Tretinoin: In Vitro Evaluation of Drug Permeation and Vesicle-Skin Interaction","volume":"103","author":"Sinico","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2007.05.061","article-title":"Solid Lipid Nanoparticles (SLN) of Tretinoin: Potential in Topical Delivery","volume":"345","author":"Shah","year":"2007","journal-title":"Int. J. Pharm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0731-7085(01)00502-7","article-title":"Liposomes with Tretinoin: A Physical and Chemical Evaluation","volume":"26","author":"Brisaert","year":"2001","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2005.11.045","article-title":"Niosomes as Carriers for Tretinoin: III. A Study into the in Vitro Cutaneous Delivery of Vesicle-Incorporated Tretinoin","volume":"311","author":"Manconi","year":"2006","journal-title":"Int. J. Pharm."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/BF00577761","article-title":"Liposomal Tretinoin for Uncomplicated Acne Vulgaris","volume":"72","author":"Korting","year":"1994","journal-title":"Clin. Investig."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1081\/PDT-100102029","article-title":"Topical Liposomal Gel of Tretinoin for the Treatment of Acne: Research and Clinical Implications","volume":"5","author":"Patel","year":"2000","journal-title":"Pharm. Dev. Technol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3109\/10717544.2015.1041578","article-title":"Drug Delivery Tretinoin-Loaded Liposomal Formulations: From Lab to Comparative Clinical Study in Acne Patients Tretinoin-Loaded Liposomal Formulations: From Lab to Comparative Clinical Study in Acne Patients","volume":"23","author":"Rahman","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijpharm.2011.03.068","article-title":"Penetration Enhancer Containing Vesicles as Carriers for Dermal Delivery of Tretinoin","volume":"412","author":"Manconi","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2014.10.031","article-title":"Development of Novel Diolein-Niosomes for Cutaneous Delivery of Tretinoin: Influence of Formulation and in Vitro Assessment","volume":"477","author":"Manca","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40199-016-0142-0","article-title":"Statistical Optimization of Tretinoin-Loaded Penetration-Enhancer Vesicles (PEV) for Topical Delivery","volume":"24","author":"Bavarsad","year":"2016","journal-title":"DARU J. Pharm. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000211477","article-title":"Sebaceous-Gland Deposition of Isotretinoin after Topical Application: An in Vitro Study Using Human Facial Skin","volume":"10","author":"Tschan","year":"1997","journal-title":"Ski. Pharmacol. Physiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1208\/s12249-010-9411-2","article-title":"Drug-Cyclodextrin-Vesicles Dual Carrier Approach for Skin Targeting of Anti-Acne Agent","volume":"11","author":"Kaur","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1518-5","article-title":"Development and Investigation of Vitamin C-Enriched Adapalene-Loaded Transfersome Gel: A Collegial Approach for the Treatment of Acne Vulgaris","volume":"21","author":"Vasanth","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2217\/nnm-2018-0002","article-title":"Codelivery of Benzoyl Peroxide & Adapalene Using Modified Liposomal Gel for Improved Acne Therapy","volume":"13","author":"Jain","year":"2018","journal-title":"Nanomedicine"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/2211738504666160804154213","article-title":"Development and Comparison of Nanosponge and Niosome Based Gel for the Topical Delivery of Tazarotene","volume":"4","author":"Aggarwal","year":"2016","journal-title":"Pharm. Nanotechnol."},{"key":"ref_86","unstructured":"(2024, February 10). Retin-A Micro\u00ae (Tretinoin) Gel Microsphere 0.1%, 0.08%, 0.06% and 0.04%. Available online: https:\/\/www.retinamicro.com\/globalassets\/bhc\/pi\/retin-a-micro-gel-pi.pdf."},{"key":"ref_87","first-page":"s2","article-title":"Tretinoin Microsphere Gel in Facial Acne Vulgaris: A Meta-Analysis","volume":"7","author":"Nighland","year":"2008","journal-title":"J. Drugs Dermatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/02652049609026042","article-title":"The Microsponge\u00ae Delivery System (MDS): A Topical Delivery System with Reduced Irritancy Incorporating Multiple Triggering Mechanisms for the Release of Actives","volume":"13","author":"Embil","year":"1996","journal-title":"J. Microencapsul."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijpharm.2008.06.028","article-title":"Development of SLNs from Natural Lipids: Application to Topical Delivery of Tretinoin","volume":"363","author":"Mandawgade","year":"2008","journal-title":"Int. J. Pharm."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.colsurfb.2011.11.051","article-title":"Chitosan-Solid Lipid Nanoparticles as Carriers for Topical Delivery of Tretinoin","volume":"93","author":"Ridolfi","year":"2012","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejpb.2016.07.026","article-title":"Nanostructured Lipid Carriers for the Topical Delivery of Tretinoin","volume":"108","author":"Ghate","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00403-021-02256-5","article-title":"Efficacy Assessments of Tretinoin-Loaded Nano Lipid Carriers in Acne Vulgaris: A Double Blind, Split-Face Randomized Clinical Study","volume":"314","author":"Samadi","year":"2022","journal-title":"Arch. Dermatol. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000488993","article-title":"Tretinoin Loaded Nanoemulsion for Acne Vulgaris: Fabrication, Physicochemical and Clinical Efficacy Assessments","volume":"31","author":"Sabouri","year":"2018","journal-title":"Ski. Pharmacol. Physiol."},{"key":"ref_94","first-page":"575","article-title":"Safety Assessment of Tretinoin Loaded Nano Emulsion and Nanostructured Lipid Carriers: A Non-Invasive Trial on Human Volunteers","volume":"14","author":"Nasrollahi","year":"2016","journal-title":"Curr. Drug Deliv."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijpharm.2013.10.007","article-title":"Nanosuspension Improves Tretinoin Photostability and Delivery to the Skin","volume":"458","author":"Lai","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e12483","DOI":"10.1111\/dth.12483","article-title":"Adverse Effects of Isotretinoin: A Large, Retrospective Review","volume":"30","author":"Brzezinski","year":"2017","journal-title":"Dermatol. Ther."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2006.08.007","article-title":"Isotretinoin-Loaded Solid Lipid Nanoparticles with Skin Targeting for Topical Delivery","volume":"328","author":"Liu","year":"2007","journal-title":"Int. J. Pharm."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2478\/v10007-012-0032-z","article-title":"Improved Photostability, Reduced Skin Permeation and Irritation of Isotretinoin by Solid Lipid Nanoparticles","volume":"62","author":"Shiva","year":"2012","journal-title":"Acta Pharm."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/02652048.2020.1823499","article-title":"Isotretinoin and \u03b1-Tocopherol Acetate-Loaded Solid Lipid Nanoparticle Topical Gel for the Treatment of Acne","volume":"37","author":"Gupta","year":"2020","journal-title":"J Microencapsul"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/jps.23627","article-title":"Adapalene Microemulsion for Transfollicular Drug Delivery","volume":"102","author":"Bhatia","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2014.02.050","article-title":"Development, Formulation, and Characterization of an Adapalene-Loaded Solid Lipid Microparticle Dispersion for Follicular Penetration","volume":"466","author":"Lauterbach","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1007\/s11095-014-1398-z","article-title":"Acid-Responsive Polymeric Nanocarriers for Topical Adapalene Delivery","volume":"31","author":"Guo","year":"2014","journal-title":"Pharm. Res."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Pullar, J.M., Carr, A.C., and Vissers, M.C.M. (2017). The Roles of Vitamin C in Skin Health. Nutrients, 9.","DOI":"10.3390\/nu9080866"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Arooj, A., Rehman, A.U., Iqbal, M., Naz, I., Alhodaib, A., and Ahmed, N. (2023). Development of Adapalene Loaded Liposome Based Gel for Acne. Gels, 9.","DOI":"10.3390\/gels9020135"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40257-018-0352-y","article-title":"Prevention and Reduction of Atrophic Acne Scars with Adapalene 0.3%\/Benzoyl Peroxide 2.5% Gel in Subjects with Moderate or Severe Facial Acne: Results of a 6-Month Randomized, Vehicle-Controlled Trial Using Intra-Individual Comparison","volume":"19","author":"Bissonnette","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40257-019-00454-6","article-title":"Long-Term Effectiveness and Safety of Up to 48 Weeks\u2019 Treatment with Topical Adapalene 0.3%\/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne","volume":"20","author":"Bissonnette","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40257-016-0178-4","article-title":"Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %\/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study","volume":"17","author":"Weiss","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.colsurfb.2014.05.041","article-title":"Adapalene Loaded Solid Lipid Nanoparticles Gel: An Effective Approach for Acne Treatment","volume":"121","author":"Jain","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s13346-015-0261-z","article-title":"Formulation and Evaluation of Adapalene-Loaded Nanoparticulates for Epidermal Localization","volume":"5","author":"Bhalekar","year":"2015","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-020-02866-0","article-title":"Ion Pair Strategy in Solid Lipid Nanoparticles: A Targeted Approach to Improve Epidermal Targeting with Controlled Adapalene Release, Resulting Reduced Skin Irritation","volume":"37","author":"Rodrigues","year":"2020","journal-title":"Pharm. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejps.2018.04.029","article-title":"Delivery of Adapalene Using a Novel Topical Gel Based on Tea Tree Oil Nano-Emulsion: Permeation, Antibacterial and Safety Assessments","volume":"120","author":"Ghaemi","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.xphs.2017.05.038","article-title":"Mechanistic Analysis of Human Skin Distribution and Follicular Targeting of Adapalene-Loaded Biodegradable Nanospheres With an Insight Into Hydrogel Matrix Influence, In Vitro Skin Irritation, and In Vivo Tolerability","volume":"106","author":"Sallam","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nano.2016.08.008","article-title":"Development and Characterization of Polymeric Nanoparticle-Based Formulation of Adapalene for Topical Acne Therapy","volume":"13","author":"Ramezanli","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1039\/C7NR07706H","article-title":"Selective Delivery of Adapalene to the Human Hair Follicle under Finite Dose Conditions Using Polymeric Micelle Nanocarriers","volume":"10","author":"Kandekar","year":"2018","journal-title":"Nanoscale"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s13346-021-00933-6","article-title":"Dermal Delivery and Follicular Targeting of Adapalene Using PAMAM Dendrimers","volume":"11","author":"Boran","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.msec.2017.05.036","article-title":"Performance Evaluation of Non-Ionic Surfactant Based Tazarotene Encapsulated Proniosomal Gel for the Treatment of Psoriasis","volume":"79","author":"Prasad","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/jdv.16686","article-title":"Antibiotic Resistance in Acne: Changes, Consequences and Concerns","volume":"35","author":"Karadag","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/bjd.21739","article-title":"A Systematic Review and Network Meta-Analysis of Topical Pharmacological, Oral Pharmacological, Physical and Combined Treatments for Acne Vulgaris","volume":"187","author":"Mavranezouli","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"R044","DOI":"10.1007\/s004240000000","article-title":"Development of Liposome Encapsulated Clindamycin for Treatment of Acne Vulgaris","volume":"440","author":"Honzak","year":"2000","journal-title":"Pfl\u00fcgers Arch."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s12272-009-1713-0","article-title":"Physicochemical Characterization and Skin Permeation of Liposome Formulations Containing Clindamycin Phosphate","volume":"32","author":"Shanmugam","year":"2009","journal-title":"Arch. Pharm. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1208\/s12249-015-0441-7","article-title":"Transfersomal Nanoparticles for Enhanced Transdermal Delivery of Clindamycin","volume":"17","author":"Abdellatif","year":"2016","journal-title":"AAPS PharmSciTech"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4103\/1735-5362.236831","article-title":"Improvement of Dermal Delivery of Tetracycline Using Vesicular Nanostructures","volume":"13","author":"Hasanpouri","year":"2018","journal-title":"Res. Pharm. Sci."},{"key":"ref_123","first-page":"263","article-title":"Liposome-Based Combination Therapy for Acne Treatment","volume":"30","author":"Aslan","year":"2019","journal-title":"J. Liposome Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejpb.2017.01.006","article-title":"Topical Delivery of Roxithromycin Solid-State Forms Entrapped in Vesicles","volume":"114","author":"Csongradi","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1208\/s12249-018-1025-0","article-title":"Dapsone-Loaded Invasomes as a Potential Treatment of Acne: Preparation, Characterization, and In Vivo Skin Deposition Assay","volume":"19","author":"Shamma","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of Care for the Management of Acne Vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_127","unstructured":"Brunton, L.L., Chabner, B.A., and Knollmann, B.C. (2011). Goodman & Gilman\u2019s. The Pharmacological Basis of Therapeutics, McGraw-Hill."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2165\/00003495-200363150-00005","article-title":"Current Concepts of the Pathogenesis of Acne","volume":"63","author":"Gollnick","year":"2003","journal-title":"Drugs"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s12045-009-0084-7","article-title":"Polymorphism: An Overview","volume":"14","author":"Purohit","year":"2009","journal-title":"Resonance"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/10717544.2022.2048131","article-title":"D-Optimal Mixture Design for Optimization of Topical Dapsone Niosomes: In Vitro Characterization and in Vivo Activity against Cutibacterium Acnes","volume":"29","author":"Habib","year":"2022","journal-title":"Drug Deliv."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08982104.2019.1577256","article-title":"Bilosomes as a Novel Carrier for the Cutaneous Delivery for Dapsone as a Potential Treatment of Acne: Preparation, Characterization and in Vivo Skin Deposition Assay","volume":"30","author":"Shamma","year":"2020","journal-title":"J. Liposome Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2174\/2211738506666181105141522","article-title":"Formulation and Optimization of Topical Solid Lipid Nanoparticles Based Gel of Dapsone Using Design of Experiment","volume":"6","author":"Deshkar","year":"2019","journal-title":"Pharm. Nanotechnol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1208\/s12249-023-02564-1","article-title":"Dapsone-Loaded Mixed Micellar Gel for Treatment OF Acne Vulgaris","volume":"24","author":"Rao","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000093984","article-title":"\u2018Keratolytic\u2019 Properties of Benzoyl Peroxide and Retinoic Acid Resemble Salicylic Acid in Man","volume":"19","author":"Waller","year":"2006","journal-title":"Ski. Pharmacol. Physiol."},{"key":"ref_135","first-page":"5","article-title":"Benzoyl Peroxide: Enhancing Antibiotic Efficacy in Acne Management","volume":"15","author":"Dutil","year":"2010","journal-title":"Ski. Ther. Lett."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2165\/11208170-000000000-00000","article-title":"Adapalene 0.1%\/Benzoyl Peroxide 2.5% Gel: A Review of Its Use in the Treatment of Acne Vulgaris in Patients Aged \u2265 12 Years","volume":"12","author":"Keating","year":"2011","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_137","first-page":"16","article-title":"Del Efficacy and Tolerability of a Three-Step Acne System Containing a Solubilized Benzoyl Peroxide Lotion versus a Benzoyl Peroxide\/Clindamycin Combination Product: An Investigator-Blind, Randomized, Parallel-Group Study","volume":"1","author":"Green","year":"2008","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"ref_138","first-page":"1341","article-title":"Benzoyl Peroxide Solubility and Stability in Hydric Solvents","volume":"9","author":"Chellquist","year":"1992","journal-title":"Pharm. Res. Off. J. Am. Assoc. Pharm. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000018129","article-title":"Antibacterial Efficacy of Benzoyl Peroxide in Phospholipid Liposomes","volume":"198","author":"Fluhr","year":"1999","journal-title":"Dermatology"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1081\/DDC-100107251","article-title":"Preparation and Comparative Clinical Evaluation of Liposomal Gel of Benzoyl Peroxide for Acne","volume":"27","author":"Patel","year":"2001","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/pt0203_tn4","article-title":"Clinical Assessment of the Combination Therapy with Liposomal Gels of Tretinoin and Benzoyl Peroxide in Acne","volume":"2","author":"Patel","year":"2001","journal-title":"AAPS PharmSciTech"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejps.2016.11.017","article-title":"Successful Co-Encapsulation of Benzoyl Peroxide and Chloramphenicol in Liposomes by a Novel Manufacturing Method-Dual Asymmetric Centrifugation","volume":"97","author":"Ingebrigtsen","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_143","first-page":"171","article-title":"Formulation and Evaluation of a Topical Niosomal Gel Containing a Combination of Benzoyl Peroxide and Tretinoin for Antiacne Activity","volume":"10","author":"Gupta","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000354888","article-title":"Azelaic Acid: Properties and Mode of Action","volume":"27","author":"Sieber","year":"2013","journal-title":"Ski. Pharmacol. Physiol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/jdv.13541","article-title":"A Multicentre, Randomized, Single-Blind, Parallel-Group Study Comparing the Efficacy and Tolerability of Benzoyl Peroxide 3%\/Clindamycin 1% with Azelaic Acid 20% in the Topical Treatment of Mild-to-Moderate Acne Vulgaris","volume":"30","author":"Schaller","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijpharm.2019.04.016","article-title":"Preparation of in Situ Hydrogels Loaded with Azelaic Acid Nanocrystals and Their Dermal Application Performance Study","volume":"563","author":"Jug","year":"2019","journal-title":"Int. J. Pharm."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1017\/S1431927613000536","article-title":"Development and Evaluation of a Novel Topical Treatment for Acne with Azelaic Acid-Loaded Nanoparticles","volume":"19","author":"Reis","year":"2013","journal-title":"Microsc. Microanal."},{"key":"ref_148","first-page":"253","article-title":"Ethosomes and Liposomes as Topical Vehicles for Azelaic Acid: A Preformulation Study","volume":"55","author":"Esposito","year":"2004","journal-title":"J. Cosmet. Sci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpharm.2009.02.010","article-title":"Temoporfin-Loaded Liposomal Gels: Viscoelastic Properties and in Vitro Skin Penetration","volume":"373","author":"Winter","year":"2009","journal-title":"Int. J. Pharm."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0960327109105164","article-title":"Safety Assessment of Azelaic Acid and Its Derivatives Entrapped in Nanovesicles","volume":"28","author":"Panyosak","year":"2009","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.biopha.2016.07.014","article-title":"New Effective Azelaic Acid Liposomal Gel Formulation of Enhanced Pharmaceutical Bioavailability","volume":"83","author":"Burchacka","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ijpharm.2015.05.042","article-title":"LeciPlex, Invasomes, and Liposomes: A Skin Penetration Study","volume":"490","author":"Shah","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/jocd.12340","article-title":"A Peel-off Facial Mask Comprising Myoinositol and Trehalose-Loaded Liposomes Improves Adult Female Acne by Reducing Local Hyperandrogenism and Activating Autophagy","volume":"16","author":"Fabbrocini","year":"2017","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1016\/j.biomaterials.2009.07.033","article-title":"The Antimicrobial Activity of Liposomal Lauric Acids against Propionibacterium Acnes","volume":"30","author":"Yang","year":"2009","journal-title":"Biomaterials"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e02648","DOI":"10.1016\/j.heliyon.2019.e02648","article-title":"Characterization of Phospholipid Vesicles Containing Lauric Acid: Physicochemical Basis for Process and Product Development","volume":"5","author":"Farkuh","year":"2019","journal-title":"Heliyon"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1080\/03639045.2018.1546310","article-title":"Design, Preparation, and Evaluation of Liposomal Gel Formulations for Treatment of Acne: In Vitro and in Vivo Studies","volume":"45","author":"Madan","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2147\/IJN.S84035","article-title":"Recent Insights into the Biological Activities and Drug Delivery Systems of Tanshinones","volume":"11","author":"Chen","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Chandel, A.K.S., and Bhingradiya, N. (2021). Enhancing the Therapeutic Efficacy of Herbal Formulations, IGI Global.","DOI":"10.4018\/978-1-7998-4453-2.ch001"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Yu, Z., Lv, H., Han, G., and Ma, K. (2016). Ethosomes Loaded with Cryptotanshinone for Acne Treatment through Topical Gel Formulation. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0159967"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/exd.13934","article-title":"Salicylic Acid Treats Acne Vulgaris by Suppressing AMPK\/SREBP1 Pathway in Sebocytes","volume":"28","author":"Lu","year":"2019","journal-title":"Exp. Dermatol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1080\/09546634.2018.1442552","article-title":"Clinical Evidence for Washing and Cleansers in Acne Vulgaris: A Systematic Review","volume":"29","author":"Stringer","year":"2018","journal-title":"J. Dermatol. Treat."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/CCID.S193730","article-title":"The Efficacy of Glycolic Acid, Salicylic Acid, Gluconolactone, and Licochalcone A Combined with 0.1% Adapalene vs Adapalene Monotherapy in Mild-to-Moderate Acne Vulgaris: A Double-Blinded within-Person Comparative Study","volume":"12","author":"Kantikosum","year":"2019","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/09546634.2018.1484876","article-title":"Clinical and Dermoscopic Evaluation of Combined (Salicylic Acid 20% and Azelaic Acid 20%) versus Trichloroacetic Acid 25% Chemical Peel in Acne: An RCT","volume":"30","author":"Hegazy","year":"2019","journal-title":"J. Dermatol. Treat."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1081\/DDC-120018380","article-title":"Preparation, Optimization, Characterization, and Stability Studies of Salicylic Acid Liposomes","volume":"29","author":"Bhalerao","year":"2003","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1346-8138.2009.00778.x","article-title":"Selective Induction of Apoptosis in the Hamster Flank Sebaceous Gland Organ by a Topical Liposome 5-\u03b1-Reductase Inhibitor: A Treatment Strategy for Acne","volume":"37","author":"Li","year":"2010","journal-title":"J. Dermatol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.chemphyslip.2007.04.009","article-title":"The Influence of Selected Steroid Hormones on the Physicochemical Behaviour of DPPC Liposomes","volume":"148","author":"Biruss","year":"2007","journal-title":"Chem. Phys. Lipids"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0378-5173(03)00180-7","article-title":"Permeation of Cyproterone Acetate through Pig Skin from Different Vehicles with Phospholipids","volume":"258","author":"Valenta","year":"2003","journal-title":"Int. J. Pharm."},{"key":"ref_168","first-page":"199","article-title":"Preparation and Evaluation of Cyproterone Acetate Liposome for Topical Drug Delivery","volume":"5","author":"Samani","year":"2009","journal-title":"Iran. J. Pharm. Sci."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/10715760500473834","article-title":"Antioxidant and Antimicrobial Activities of Rosemary Extracts Linked to Their Polyphenol Composition","volume":"40","author":"Moreno","year":"2006","journal-title":"Free Radic. Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3109\/10717544.2014.903010","article-title":"Development and Characterization of a Novel Antiacne Niosomal Gel of Rosmarinic Acid","volume":"22","author":"Budhiraja","year":"2015","journal-title":"Drug Deliv."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijantimicag.2014.10.011","article-title":"Treatment of Acne with Tea Tree Oil (Melaleuca) Products: A Review of Efficacy, Tolerability and Potential Modes of Action","volume":"45","author":"Hammer","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/ajd.12465","article-title":"Tea Tree Oil Gel for Mild to Moderate Acne; a 12 Week Uncontrolled, Open-Label Phase II Pilot Study","volume":"58","author":"Malhi","year":"2017","journal-title":"Australas. J. Dermatol."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Nascimento, T., Gomes, D., Sim\u00f5es, R., and da Gra\u00e7a Miguel, M. (2023). Tea Tree Oil: Properties and the Therapeutic Approach to Acne\u2014A Review. Antioxidants, 12.","DOI":"10.3390\/antiox12061264"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2007.10.002","article-title":"Human Skin Penetration of the Major Components of Australian Tea Tree Oil Applied in Its Pure Form and as a 20% Solution in Vitro","volume":"69","author":"Cross","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jps.20250","article-title":"Tea Tree Oil Concentration in Follicular Casts after Topical Delivery: Determination by High-Performance Thin Layer Chromatography Using a Perfused Bovine Udder Model","volume":"94","author":"Biju","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.2174\/1381612826666200305124041","article-title":"Therapeutic Potential of Melaleuca Alternifolia Essential Oil in New Drug Delivery Systems","volume":"26","author":"Formiga","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/08982104.2014.987786","article-title":"Development of Tea Tree Oil-Loaded Liposomal Formulation Using Response Surface Methodology","volume":"25","author":"Ge","year":"2015","journal-title":"J. Liposome Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/lam.12082","article-title":"Antimicrobial Efficacy of Liposome-Encapsulated Silver Ions and Tea Tree Oil against Pseudomonas Aeruginosa, Staphylococcus Aureus and Candida Albicans","volume":"57","author":"Low","year":"2013","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1517\/17425247.2012.697894","article-title":"Liposomes in Topical Photodynamic Therapy","volume":"9","author":"Fahr","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_180","first-page":"983","article-title":"Liposomal Methylene Blue Hydrogel for Selective Photodynamic Therapy of Acne Vulgaris","volume":"8","author":"Fadel","year":"2009","journal-title":"J. Drugs Dermatol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00403-016-1639-6","article-title":"Intense Pulsed Light versus Photodynamic Therapy Using Liposomal Methylene Blue Gel for the Treatment of Truncal Acne Vulgaris: A Comparative Randomized Split Body Study","volume":"308","author":"Moftah","year":"2016","journal-title":"Arch. Dermatol. Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1002\/adhm.201600815","article-title":"Lipase-Sensitive Transfersomes Based on Photosensitizer\/Polymerizable Lipid Conjugate for Selective Antimicrobial Photodynamic Therapy of Acne","volume":"5","author":"Park","year":"2016","journal-title":"Adv. Healthc. Mater."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1524-4725.2011.01929.x","article-title":"Liposome-Encapsulated 0.5% 5-Aminolevulinic Acid with Intense Pulsed Light for the Treatment of Inflammatory Facial Acne: A Pilot Study","volume":"37","author":"Yeung","year":"2011","journal-title":"Dermatol. Surg."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1468-3083.2009.03447.x","article-title":"Photodynamic Therapy of Acne Vulgaris Using 5-Aminolevulinic Acid 0.5% Liposomal Spray and Intense Pulsed Light in Combination with Topical Keratolytic Agents","volume":"24","author":"Bjerring","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_185","unstructured":"Loden, M., and Maibach, H.I. (2000). Dry Skin and Moisturizers. Chemistry and Function, CRC Press."},{"key":"ref_186","unstructured":"Loden, M., and Maibach, H.I. (2000). Dry Skin and Moisturizers. Chemistry and Function, CRC Press."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1365-2133.2000.03531.x","article-title":"Comedogenesis: Some New Aetiological, Clinical and Therapeutic Strategies","volume":"142","author":"Cunliffe","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0190-9622(86)70025-X","article-title":"Essential Fatty Acids and Acne","volume":"14","author":"Downing","year":"1986","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"LETAWE, BOONE, and PI\u00c9RARD (1998). Digital Image Analysis of the Effect of Topically Applied Linoleic Acid on Acne Microcomedones. Clin. Exp. Dermatol., 23, 56\u201358.","DOI":"10.1046\/j.1365-2230.1998.00315.x"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and Challenges of Liposome Assisted Drug Delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Kenchegowda, M., Rahamathulla, M., Hani, U., Begum, M.Y., Guruswamy, S., Osmani, R.A.M., Gowrav, M.P., Alshehri, S., Ghoneim, M.M., and Alshlowi, A. (2021). Smart Nanocarriers as an Emerging Platform for Cancer Therapy: A Review. Molecules, 27.","DOI":"10.3390\/molecules27010146"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/3\/309\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:03:23Z","timestamp":1760105003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/3\/309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":191,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["pharmaceutics16030309"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics16030309","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]}}}